Enquire Now

Specialty Pharmaceutical Solutions for Better Therapeutic Care

MERGA Division delivers focused pharmaceutical solutions across Neurology, Pain Management, Cardiology, Diabetology, Psychiatry, and Gastroenterology. Our specialty portfolio is designed to support acute conditions, chronic-care needs, and long-term patient wellness through targeted therapeutic solutions.
Contact Us

ABOUT MERGA

Specialty Care Across Key Therapeutic Areas

MERGA Division is a specialty pharmaceutical division focused on delivering targeted therapeutic solutions across Neurology, Pain Management, Cardiology, Diabetology, Psychiatry, and Gastroenterology.

Our portfolio combines prescription medicines and supportive formulations addressing acute neurological conditions, chronic pain, hypertension, diabetes, mood disorders, gastrointestinal disorders, and nutritional needs. With an emphasis on specialty and chronic-care segments, MERGA is focused on supporting healthcare professionals with reliable therapeutic options for diverse patient needs.

IMG_0199

OUR CORE FOCUS

Focused Care Across Key Therapeutic Areas

MERGA brings together a focused portfolio of pharmaceutical and supportive formulations across key therapeutic areas, addressing diverse acute, chronic, and specialty-care needs.

Neurology & Stroke Care

Focused therapeutic solutions supporting neurological and stroke-care needs.

Neuropathic Pain & Pain Management

Targeted solutions for neuropathic, musculoskeletal, and chronic pain management.

Cardiology & Hypertension

Therapeutic options supporting blood-pressure management and cardiovascular care.

Diabetology & Metabolic Care

Pharmaceutical solutions supporting glycaemic and metabolic care.

Psychiatry & Mental Health

Specialty formulations supporting the management of selected mood and mental-health conditions.

Pharmaceutical formulation ingredients icon

Neuro-Vitamin & Nutritional Support

Nutritional and vitamin-based formulations supporting neurological and broader nutritional needs.

Gastroenterology

Therapeutic solutions addressing acid-related and gastrointestinal care needs.

One Division. Multiple Therapeutic Needs. Focused Specialty Care.

MERGA DIVISION

Our Specialty Brand Portfolio

Explore the MERGA portfolio of specialty pharmaceutical products across key therapeutic areas, supporting diverse clinical and chronic-care needs.

Neuro-Rehabilitation, Psychiatry & Gastroenterology

Complementing the MERGA portfolio, these products support specialized needs across neuro-rehabilitation, mental health and gastrointestinal care.

REGENERVE ®
Neuro-Rehabilitation / Supportive Care

Nutritional formulation combining energy-metabolism, amino-acid and neuro-supportive ingredients to support rehabilitation.

View Product →
PSYVEN® XR 37.5 / 75 / 150
Psychiatry / Depression & Anxiety

Extended-release SNRI formulation used in the management of depressive and anxiety-spectrum disorders as clinically indicated

View Product →
PANSELOZ®-40
Gastroenterology

Proton-pump inhibitor used to reduce gastric acid secretion in acid-related gastrointestinal disorders.

View Product →

Neurology & Stroke Care

Targeted pharmaceutical solutions supporting neurological and stroke-related care across acute and chronic therapeutic needs.

EDANUS® Inj
Neurology / Stroke Care

Injectable edaravone formulation positioned for specialist neurological care, including conditions where edaravone therapy is clinically indicated.

View Product →
SEGIPRED® Inj 500
Critical Care / Neurology / Steroid Therapy

Injectable corticosteroid formulation used in selected acute inflammatory and immune-mediated conditions under medical supervision.

View Product →
PENTINUS® SR 300
Neurology / Neuropathic Pain

Extended-release gabapentin formulation for neuropathic pain and selected neurological indications where gabapentin is appropriate.

View Product →

Pain Management & Orthopaedics

Targeted formulations supporting pain management and complementary care across neuropathic and musculoskeletal conditions.

PENTINUS® Ointment
Pain Management / Orthopaedics

Topical multi-modal analgesic formulation positioned for localized neuropathic and musculoskeletal pain management.

View Product →
PALMISIS™
Pain Management / Ortho-Neuro Support

Supportive formulation combining PEA with complementary nutritional ingredients for chronic pain-management strategies.

View Product →

Neuro-Vitamin & Nutritional Support

Supportive formulations designed to provide targeted nutritional and neuro-vitamin support across neurological and diabetic-care needs.

SEGIMINE® In
Neuro-Vitamin / Supportive Care

Injectable B-vitamin formulation providing nutritional support in vitamin deficiency and neurological conditions requiring increased B-vitamin support.

View Product →
SEGIMINE® FORTE
Diabetic Neuropathy / Nutritional Support

Comprehensive nutritional formulation providing micronutritional support for patients with increased nutritional needs associated with diabetes and neuropathic conditions.

View Product →

Cardiology & Hypertension

A focused portfolio of antihypertensive formulations designed to support blood-pressure management and cardiovascular care.

SEGITEL® 40
Cardiology / Hypertension

Telmisartan-based antihypertensive formulation for blood-pressure management and cardiovascular risk reduction where clinically indicated.

View Product →
SEGITEL® AM
Cardiology / Hypertension

Dual antihypertensive formulation combining an ARB and calcium-channel blocker for complementary blood-pressure control.

View Product →
SEGITEL® LN
Cardiology / Hypertension

Combination antihypertensive formulation providing dual-agent therapy for blood-pressure management where clinically appropriate.

View Product →
SEGITEL® H
Cardiology / Hypertension

ARB–thiazide combination formulated to provide additional blood-pressure control where clinically appropriate.

View Product →
SEGITEL® BETA
Cardiology / Hypertension

Combination cardiovascular formulation integrating ARB-based blood-pressure control with beta-blockade.

View Product →

Diabetology & Metabolic Care

Targeted oral formulations supporting glycaemic control and metabolic care across appropriate diabetes-management needs.

JUXRA®-10
Diabetology / Metabolic Care

SGLT2 inhibitor formulation used for glycaemic control and approved cardio-renal indications where clinically appropriate.

View Product →
JUXRA®-S
Diabetology

Dual oral antidiabetic formulation combining SGLT2 and DPP-4 inhibition for complementary glycaemic control.

View Product →
JUXRA®-L
Diabetology

Dual oral antidiabetic formulation combining SGLT2 and DPP-4 inhibition for complementary glucose-lowering therapy.

View Product →
GUA-G1
Diabetology

Oral antidiabetic combination of glimepiride and metformin for glycaemic control in appropriate patients with type 2 diabetes.

View Product →
GUA-G2
Diabetology

Oral antidiabetic combination of glimepiride and metformin for glycaemic control in appropriate patients with type 2 diabetes.

View Product →

Focused Solutions. Diverse Therapeutic Needs.

Explore our diverse range of pharmaceutical products developed to support healthcare needs across multiple therapeutic areas. Discover our complete product portfolio and learn more about our solutions.

Contact Us

Seginus is a well-known pharmaceutical firm in Tamil Nadu. We are one of the leading and fastest growing pharmaceutical firms, having consistently followed the route created by its efforts, hard work, customer service, and determination.

Quick Links

Home

About Us

Products

Services

Distributors

Contact Us

Contact Info

  • Address

76/4 & 76/5, Ground Floor,

Tasbeeh building,

Perumal sannathi street, Tirunelveli,

TamilNadu – 627001

Monday to Saturday 10am — 5pm

© Copyright 2026. All Rights Reserved. Seginuspharma.